CORT · ISSUER CIK 1088856
CORCEPT THERAPEUTICS INC
Between Aug 1, 2026 and Oct 29, 2026, 9 CORCEPT THERAPEUTICS INC insiders reported $0.00 of open-market purchases and $53.9M of sales on SEC Form 4.
↗9 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 18 of 21 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$53.9MInsider selling
−$53.9MNet open-market
Oct 16, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 202618:24 | Oct 15, 2026 | CORT | Director | S · Sell10b5-1 | $114.81 | −10,000 | 1,054,543 | -1% | −$1.1M | ||
| Oct 5, 202619:58 | Oct 2, 2026 | CORT | President, Oncology | S · Sell10b5-1 | $116.10 | −8,333 | 3,946 | -68% | −$967K | ||
| Oct 5, 202619:58 | Oct 2, 2026 | CORT | President, Oncology | M · Exercise10b5-1 | $21.63 | +8,333 | 12,279 | +211% | $180K | ||
| Oct 5, 202619:54 | Oct 2, 2026from Oct 1, 2026 | CORT | See Remarks | S · Sell10b5-1 | $116.07 | −10,000 | 5,683 | -64% | −$1.2M | ||
| Oct 5, 202619:54 | Oct 2, 2026from Oct 1, 2026 | CORT | See Remarks | M · Exercise10b5-1 | $16.88 | +10,000 | 14,873 | +205% | $169K | ||
| Oct 5, 202619:49 | Oct 2, 2026from Oct 1, 2026 | CORT | See Remarks | S · Sell10b5-1 | $116.26 | −25,000 | 9,938 | -72% | −$2.9M | ||
| Oct 5, 202619:49 | Oct 2, 2026from Oct 1, 2026 | CORT | See Remarks | M · Exercise10b5-1 | $8.27 | +25,000 | 34,525 | +262% | $207K | ||
| Sep 28, 202616:30 | Sep 24, 2026 | CORT | Chief Business Officer | G · Gift | — | −17,100 | 14,056 | -55% | — | ||
| Sep 28, 202616:30 | Sep 24, 2026 | CORT | Chief Business Officer | G · Gift | — | +10,000 | 20,571 | +95% | — | ||
| Sep 18, 202619:53 | Sep 16, 2026 | CORT | President, Oncology | S · Sell10b5-1 | $100.82 | −296 | 3,946 | -7% | −$30K | ||
| Sep 18, 202619:47 | Sep 17, 2026 | CORT | Chief Business Officer | M · Exercise | $8.27 | +17,493 | 31,156 | +128% | $145K | ||
| Sep 16, 202616:30 | Sep 14, 2026 | CORT | See Remarks | S · Sell10b5-1 | $113.49 | −10,000 | 5,683 | -64% | −$1.1M | ||
| Sep 16, 202616:30 | Sep 14, 2026 | CORT | See Remarks | M · Exercise10b5-1 | $12.99 | +10,000 | 15,683 | +176% | $130K | ||
| Sep 16, 202616:30 | Sep 15, 2026 | CORT | Director | S · Sell10b5-1 | $110.69 | −10,000 | 1,064,543 | -1% | −$1.1M | ||
| Sep 3, 202621:16 | Sep 1, 2026 | CORT | Chief Development Officer | A · Grant | $56.69 | +328 | 4,313 | +8% | $19K | ||
| Sep 3, 202621:16 | Sep 1, 2026 | CORT | See Remarks | S · Sell10b5-1 | $114.43 | −25,000 | 9,755 | -72% | −$2.9M | ||
| Sep 3, 202621:16 | Sep 1, 2026 | CORT | See Remarks | M · Exercise10b5-1 | $8.27 | +25,000 | 34,755 | +256% | $207K | ||
| Sep 3, 202621:16 | Sep 2, 2026 | CORT | See Remarks | F · Tax10b5-1 | $113.38 | −117 | 9,938 | -1% | $13K | ||
| Sep 3, 202621:16 | Sep 1, 2026 | CORT | See Remarks | A · Grant10b5-1 | $56.69 | +300 | 10,055 | +3% | $17K | ||
| Sep 3, 202621:06 | Sep 2, 2026 | CORT | Chief Financial Officer | F · Tax | $113.38 | −102 | 16,304 | -1% | $12K | ||
| Sep 3, 202621:06 | Sep 1, 2026 | CORT | Chief Financial Officer | A · Grant | $56.69 | +276 | 16,406 | +2% | $16K | ||
| Sep 3, 202621:03 | Sep 2, 2026 | CORT | Chief Business Officer | F · Tax | $113.38 | −91 | 13,663 | -1% | $10K | ||
| Sep 3, 202621:03 | Sep 1, 2026 | CORT | Chief Business Officer | A · Grant | $56.69 | +328 | 13,754 | +2% | $19K | ||
| Sep 3, 202621:02 | Sep 2, 2026 | CORT | President, Oncology | S · Sell10b5-1 | $110.76 | −58,333 | 4,242 | -93% | −$6.5M | ||
| Sep 3, 202621:02 | Sep 2, 2026 | CORT | President, Oncology | M · Exercise10b5-1 | $21.63 | +58,333 | 62,575 | +1375% | $1.3M | ||
| Sep 3, 202621:02 | Sep 2, 2026 | CORT | President, Oncology | F · Tax10b5-1 | $113.38 | −102 | 4,242 | -2% | $12K | ||
| Sep 3, 202621:02 | Sep 1, 2026 | CORT | President, Oncology | A · Grant10b5-1 | $56.69 | +276 | 4,344 | +7% | $16K | ||
| Sep 3, 202621:00 | Sep 2, 2026 | CORT | See Remarks | F · Tax | $113.38 | −72 | 5,683 | -1% | $8K | ||
| Sep 3, 202621:00 | Sep 1, 2026 | CORT | See Remarks | A · Grant | $56.69 | +260 | 5,755 | +5% | $15K | ||
| Aug 28, 202616:30 | Aug 26, 2026 | CORT | Director | S · Sell | $122.55 | −26,685 | 0 | -100% | −$3.3M | ||
| Aug 28, 202616:30 | Aug 26, 2026 | CORT | Director | M · Exercise | $13.49 | +30,000 | 30,000 | New | $405K | ||
| Aug 28, 202616:30 | Aug 26, 2026 | CORT | Director | F · Tax | $122.09 | −3,315 | 26,685 | -11% | $405K | ||
| Aug 27, 202616:30 | Aug 25, 2026 | CORT | See Remarks | S · Sell10b5-1 | $125.58 | −30,955 | 9,755 | -76% | −$3.9M | ||
| Aug 27, 202616:30 | Aug 25, 2026 | CORT | See Remarks | M · Exercise10b5-1 | $11.35 | +30,955 | 40,710 | +317% | $351K | ||
| Aug 20, 202616:30 | Aug 18, 2026 | CORT | Director | S · Sell10b5-1 | $118.25 | −103,606 | 1,133,539 | -8% | −$12.3M | ||
| Aug 18, 202616:30 | Aug 14, 2026 | CORT | See Remarks | S · Sell10b5-1 | $114.49 | −3,664 | 9,755 | -27% | −$419K | ||
| Aug 18, 202616:30 | Aug 14, 2026 | CORT | See Remarks | M · Exercise10b5-1 | $8.27 | +3,664 | 13,419 | +38% | $30K | ||
| Aug 18, 202616:30 | Aug 14, 2026 | CORT | Director | S · Sell10b5-1 | $111.43 | −10,000 | 1,074,543 | -1% | −$1.1M | ||
| Aug 18, 202616:30 | Aug 17, 2026 | CORT | Chief Business Officer | S · Sell | $116.26 | −10,000 | 39,716 | -20% | −$1.2M | ||
| Aug 18, 202616:30 | Aug 17, 2026 | CORT | Chief Business Officer | G · Gift | — | −125 | 13,426 | -1% | — | ||
| Aug 14, 202616:31 | Aug 12, 2026 | CORT | Chief Business Officer | G · Gift | — | −11,530 | 13,551 | -46% | — | ||
| Aug 14, 202616:31 | Aug 12, 2026 | CORT | Chief Business Officer | G · Gift | — | +6,000 | 15,571 | +63% | — | ||
| Aug 12, 202616:27 | Aug 10, 2026 | CORT | See Remarks | S · Sell10b5-1 | $114.52 | −1,031 | 9,755 | -10% | −$118K | ||
| Aug 12, 202616:27 | Aug 10, 2026 | CORT | See Remarks | M · Exercise10b5-1 | $8.27 | +1,031 | 10,786 | +11% | $9K | ||
| Aug 12, 202616:26 | Aug 10, 2026 | CORT | Chief Development Officer | S · Sell10b5-1 | $113.43 | −16,300 | 3,985 | -80% | −$1.8M | ||
| Aug 12, 202616:26 | Aug 10, 2026 | CORT | Chief Development Officer | M · Exercise10b5-1 | $21.65 | +16,300 | 20,285 | +409% | $353K | ||
| Aug 6, 202618:44 | Aug 4, 2026 | CORT | Chief Development Officer | S · Sell10b5-1 | $113.12 | −3,700 | 3,985 | -48% | −$419K | ||
| Aug 6, 202618:44 | Aug 4, 2026 | CORT | Chief Development Officer | M · Exercise10b5-1 | $21.65 | +3,700 | 7,685 | +93% | $80K | ||
| Aug 5, 202617:51 | Aug 3, 2026 | CORT | See Remarks | S · Sell10b5-1 | $114.70 | −20,305 | 9,755 | -68% | −$2.3M | ||
| Aug 5, 202617:51 | Aug 3, 2026 | CORT | See Remarks | M · Exercise10b5-1 | $8.27 | +20,305 | 30,060 | +208% | $168K |